Mangalam Organics Limited has informed the Exchange regarding 'Investor Presentation for the quarter ended June, 2025'.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Organics, a pine chemicals manufacturer (camphor, terpene and rosin derivatives), shared its investor presentation for Q1 FY26. Q1 revenue rose 24.2% to ₹146.55 Cr from ₹117.99 Cr, with PAT jumping 632% to ₹12.23 Cr (₹1.67 Cr earlier) and EBITDA up 99% at ₹21.6 Cr. EBITDA margin expanded by 554 basis points to 14.74% and PAT margin rose to 8.35%. For full-year FY25, revenue grew 7.4% to ₹530 Cr and PAT nearly tripled to ₹12.5 Cr. The company is expanding from a B2B model (96% of revenue) into B2C consumer brands like CamPure and Mangalam Camphor, with e-commerce presence on Amazon, Flipkart and others, and plans to widen its product range, geographic reach, and exports.
Strong Q1 FY26 results, with sharp margin expansion driven by lower input costs, signal improving profitability. Investors may view the B2C pivot, e-commerce growth and product diversification as positive long-term drivers, though the company still depends heavily on the single product (camphor) and pious market demand.